Search

William P. Neuder

Examiner (ID: 10341)

Most Active Art Unit
3672
Art Unit(s)
3672, 2899, 3625, 3642, 3506
Total Applications
4583
Issued Applications
4090
Pending Applications
166
Abandoned Applications
332

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19089687 [patent_doc_number] => 11951106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-09 [patent_title] => Method of increasing bioavailability and/or prolonging ophthalmic action of a drug [patent_app_type] => utility [patent_app_number] => 17/304309 [patent_app_country] => US [patent_app_date] => 2021-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 13322 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304309 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/304309
Method of increasing bioavailability and/or prolonging ophthalmic action of a drug Jun 16, 2021 Issued
Array ( [id] => 17124282 [patent_doc_number] => 20210299050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => Solid Oral Sulfate Salt Formulations For Cleansing A Colon And Methods Of Using Same [patent_app_type] => utility [patent_app_number] => 17/347469 [patent_app_country] => US [patent_app_date] => 2021-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10335 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347469 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/347469
Solid oral sulfate salt formulations for cleansing a colon and methods of using same Jun 13, 2021 Issued
Array ( [id] => 18496147 [patent_doc_number] => 20230218693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 18/000918 [patent_app_country] => US [patent_app_date] => 2021-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6669 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000918 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/000918
HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME Jun 10, 2021 Pending
Array ( [id] => 18522982 [patent_doc_number] => 20230233634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => PROCYANIDINS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION TRIGGERED BY COVID-19 [patent_app_type] => utility [patent_app_number] => 17/928797 [patent_app_country] => US [patent_app_date] => 2021-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14286 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17928797 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/928797
PROCYANIDINS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION TRIGGERED BY COVID-19 Jun 8, 2021 Pending
Array ( [id] => 18341229 [patent_doc_number] => 11638697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-02 [patent_title] => Solid oral sulfate salt formulations for cleaning a colon and methods of using same [patent_app_type] => utility [patent_app_number] => 17/340973 [patent_app_country] => US [patent_app_date] => 2021-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10395 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340973 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/340973
Solid oral sulfate salt formulations for cleaning a colon and methods of using same Jun 6, 2021 Issued
Array ( [id] => 19256947 [patent_doc_number] => 12016976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Submucosal lifting compositions and methods of same [patent_app_type] => utility [patent_app_number] => 17/335235 [patent_app_country] => US [patent_app_date] => 2021-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6724 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17335235 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/335235
Submucosal lifting compositions and methods of same May 31, 2021 Issued
Array ( [id] => 17080715 [patent_doc_number] => 20210275721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => MICROFLUIDIC EXTRUSION [patent_app_type] => utility [patent_app_number] => 17/328633 [patent_app_country] => US [patent_app_date] => 2021-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25269 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328633 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/328633
Microfluidic extrusion May 23, 2021 Issued
Array ( [id] => 17619030 [patent_doc_number] => 11338057 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-24 [patent_title] => Microfluidic extrusion [patent_app_type] => utility [patent_app_number] => 17/328854 [patent_app_country] => US [patent_app_date] => 2021-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 60 [patent_no_of_words] => 25267 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328854 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/328854
Microfluidic extrusion May 23, 2021 Issued
Array ( [id] => 18596021 [patent_doc_number] => 20230270812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => COMPOSITION TO BE USED FOR STRENGTHENING THE IMMUNE SYSTEM IN HUMAN AND ANIMAL TO ACQUIRE PAN-IMMUNITY [patent_app_type] => utility [patent_app_number] => 17/922884 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4510 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922884 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/922884
COMPOSITION TO BE USED FOR STRENGTHENING THE IMMUNE SYSTEM IN HUMAN AND ANIMAL TO ACQUIRE PAN-IMMUNITY May 6, 2021 Abandoned
Array ( [id] => 17050613 [patent_doc_number] => 20210260047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS [patent_app_type] => utility [patent_app_number] => 17/314272 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44501 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314272 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/314272
Methods and devices for the treatment of ocular diseases in human subjects May 6, 2021 Issued
Array ( [id] => 17398134 [patent_doc_number] => 20220040224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => NITRIC OXIDE TOPICAL APPLICATION APPARATUS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/244158 [patent_app_country] => US [patent_app_date] => 2021-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244158 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/244158
Nitric oxide topical application apparatus and methods Apr 28, 2021 Issued
Array ( [id] => 17035232 [patent_doc_number] => 20210252190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => Microfluidic Extrusion [patent_app_type] => utility [patent_app_number] => 17/239013 [patent_app_country] => US [patent_app_date] => 2021-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25272 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17239013 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/239013
Microfluidic extrusion Apr 22, 2021 Issued
Array ( [id] => 17020789 [patent_doc_number] => 20210244660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/236295 [patent_app_country] => US [patent_app_date] => 2021-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8739 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236295 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/236295
Orally administered corticosteroid compositions Apr 20, 2021 Issued
Array ( [id] => 17466671 [patent_doc_number] => 11273128 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-03-15 [patent_title] => Elagolix formulation [patent_app_type] => utility [patent_app_number] => 17/231118 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10665 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231118 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231118
Elagolix formulation Apr 14, 2021 Issued
Array ( [id] => 16961476 [patent_doc_number] => 20210212975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 17/219039 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15170 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219039 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/219039
STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME Mar 30, 2021 Abandoned
Array ( [id] => 18434371 [patent_doc_number] => 20230181665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES MELLITUS 10 TYPE I AND TYPE II AND THYROID DISEASES [patent_app_type] => utility [patent_app_number] => 17/912625 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26144 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912625 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/912625
TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES MELLITUS 10 TYPE I AND TYPE II AND THYROID DISEASES Mar 18, 2021 Abandoned
Array ( [id] => 19058990 [patent_doc_number] => 11938184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-26 [patent_title] => Compositions and methods for treating Crohn's Disease and related conditions and infections [patent_app_type] => utility [patent_app_number] => 17/203687 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12648 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203687 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/203687
Compositions and methods for treating Crohn's Disease and related conditions and infections Mar 15, 2021 Issued
Array ( [id] => 18994692 [patent_doc_number] => 11911511 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => Anticancer compositions [patent_app_type] => utility [patent_app_number] => 17/201811 [patent_app_country] => US [patent_app_date] => 2021-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10947 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201811 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/201811
Anticancer compositions Mar 14, 2021 Issued
Array ( [id] => 16913824 [patent_doc_number] => 20210186916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS [patent_app_type] => utility [patent_app_number] => 17/194780 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48426 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194780 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/194780
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics Mar 7, 2021 Issued
Array ( [id] => 20465377 [patent_doc_number] => 12521406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-13 [patent_title] => Use of compounds in the treatment of fungal infections [patent_app_type] => utility [patent_app_number] => 17/908079 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16505 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 224 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908079 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/908079
Use of compounds in the treatment of fungal infections Mar 1, 2021 Issued
Menu